Efficacy of corticosteroid therapy in severe decompensation of chronic obstructive pulmonary disease requiring mechanical ventilation

American Journal of Therapeutics

Volumn 20, Issue 6, 2013, Pages 630-637

  Bahloul, Mabrouk ^a   Chaari, Anis ^a   Dammak, Hassen ^a   Ammar, Rania ^a   Medhioub, Fatma ^a   Hamida, Chokri B ^a   Chelly, Hedi ^a   Bouaziz, Mounir ^a  

^a HABIB BOURGUIBA HOSPITAL   (Tunisia)

Author keywords

Chronic obstructive pulmonary disease; Corticosteroids; ICU; Outcome

Indexed keywords

CORTICOSTEROID; HYDROCORTISONE; STEROID; GLUCOCORTICOID;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; EPIDEMIOLOGICAL DATA; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; LUNG HEMODYNAMICS; MALE; MORTALITY; MORTALITY RATE; OUTCOME ASSESSMENT; OXYGEN SATURATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIMPLIFIED ACUTE PHYSIOLOGY SCORE; TIME TO TREATMENT; TREATMENT DURATION; CASE CONTROL STUDY; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX; TIME; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; GLUCOCORTICOIDS; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 84872511642     PISSN: 10752765     EISSN: 15363686     Source Type: Journal    
DOI: 10.1097/MJT.0b013e318269123e     Document Type: Article

References (19)

1. Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001;163:1256-1276.
2. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Available at: www.goldcopd.com. Accessed March 29, 2009.
3. Anthonisen NR, Manfreda J, Warren CP, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987;106:196-204.
4. Seemungal TAR, Donaldson GC, Paul EA, et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157:1418-1422.
5. Connors AF, Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. Am J Resp Crit Care Med. 1996;154:959-967.
6. Callahan CM, Dittus RS, Katz BP. Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease. A meta-analysis. Ann Intern Med. 1991; 114:216-223.
7. Snow V, Lascher S, Mottur-Pilson C. The evidence base for management of acute exacerbations of COPD: clinical practice guideline. Chest. 2001;119:1185-1189.
8. Singh JM, Palda VA, Stanbrook MB, et al. Corticosteroid therapy for patients with acute exacerbation of chronic obstructive pulmonary disease: a systematic review. Arch Intern Med. 2002;162:2527-2536.
9. Alía I, de la Cal MA, Esteban A, et al. Efficacy of corti-costeroid therapy in patients with an acute exacerbation of chronic obstructive pulmonary disease receiving ven-tilatory support. Arch Intern Med. 2011;171:1939-1946.
10. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23:932-946.
11. Le Gall JR, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270:2957-2963.
12. Bone RC. Sepsis, the sepsis syndrome, multi-organ failure: a plea for comparable definitions. Ann Intern Med. 1991;114:332-333.
13. Wouters EF, Groenewegen KH, Dentener MA, et al. Systemic inflammation in chronic obstructive pulmonary disease: the role of exacerbations. Proc Am Thorac Soc. 2007;4:626-634.
14. Qoun BS, Gan WQ, Sin DD. Contemporary management of acute exacerbations of COPD systematic review and metaanlysis Chest. 2008;133:756-766.
15. McCrory DC, Brown CD. Anticholinergic bronchodila-tors versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2002;CD003900.
16. Murata GH, Gorby MS, Chick TW, et al. Intravenous and oral corticosteroids for the prevention of relapse after treatment of decompensated COPD: effect on patients with a history of multiple relapses. Chest. 1990;98:845-849.
17. Nidwoehner DE, Erbland ML, Deupree RH, et al. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. N Engl J Med. 1999;340: 1941-1947.
18. Davies L, Angus RM, Calverley PM. Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial. Lancet. 1999;354:456-460.
19. Walters JA, Wang W, Morley C, et al. Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2011;CD006897.